Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2014 Feb 18;111(9):3514–3519. doi: 10.1073/pnas.1320198111

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Freely available online through the PNAS open access option.

PMC Copyright notice

Fig. 3. — CAMLs stain for monocytic, endothelial, and specific tissue markers. (A) CAML from a prostate cancer patient stained with DAPI (blue) and anti–cytokeratins-FITC (green) (Left) and with anti–PSMA-Dylight594 (red) (Right). (B) CAML from a pancreatic cancer patient stained with DAPI (blue) and anti–cytokeratins-FITC (green) (Left) and anti–PDX-1-Dylight594 (red) (Right). (C) CAMLs from samples from patients with breast (Upper Row) or pancreatic (Lower Row) cancer. Images from left to right show a merged image with DAPI, anti-CD11c (monocyte marker), anti-CD14 (monocyte marker), and anti-TIE-2 (angiogenic marker) staining and images of staining for individual markers. (D) CAMLs from samples from patients with breast (Upper Row) or pancreatic (Lower Row) cancer. Images from left to right show a merged image with DAPI, anti-CD11c, anti-CD14, and anti-CD146 (endothelial marker) staining and images of staining for individual markers. (Scale bars, 20 µm.)